West Pharmaceutical Services, Inc. (NYSE:WST) is expected to report third quarter earnings results, before market open, on Thursday 22nd October 2020.
Analysts polled by Thomson Reuters anticipate third quarter income of $ 0.99 per share.
Looking ahead, the full year income are expected at $ 4.25 per share on the revenues of $ 2049.28 million.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 2,035.00 million ~ $ 2,055.00 million, where as bottomline are predicted in a range of $ 4.15 ~ $ 4.25 per share
Click Here For More Historical Outlooks Of West Pharmaceutical Services, Inc.
Previous Quarter Performance
West Pharmaceutical Services, Inc. communicated income for the second quarter of $ 1.25 per share, from the revenue of $ 527.20 million. The quarterly earnings gained 40.45 percent while revenues gained 12.24 percent compared with the same quarter last year.
According to street consensus, WST was expected to report 2Q20 income of $ 0.88 per share from revenue of $ 490.58 million. The bottom line results beat street analysts by $ 0.37 or 42.05 percent, at the same time, top line results outshined analysts by $ 36.62 million or 7.46 percent.
Stock Performance
Shares of West Pharmaceutical Services, Inc. traded low $ -1.58 or -0.55 percent on Wednesday, reaching $ 285.40 with volume of 176.80 thousand shares. The stock opened positive for the day at $ 287.20, after closing the previous day trading at $ 286.98.
According to the previous trading day, closing price of $ 286.98, representing a 130.45 % increase from the 52 week low of $ 124.53 and a 5.33 % decrease over the 52 week high of $ 303.14.
The company has a market capital of $ 22.71 billion and is part of the Healthcare sector and Medical Instruments & Supplies industry.
Recent Analyst recommendations
- On 14th October 2020, initiated by Stephens at Equal-Weight rating, with $ 300.00 target price.
Recent Stock Dividend Announcement
On July 15, 2020, the board of directors authorized 3Q20 dividend of $ 0.16 per share to holders of record as of the close of business on July 29, 2020, with payment date of August 5, 2020 and ex-dividend date on July 28, 2020.
Conference Call
West Pharmaceutical Services, Inc. will be hosting a conference call at 9:00 AM eastern time on 22nd October 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.westpharma.com
West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.
